ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
Clinical trial NCT06460298 · RECRUITING
Trial details
- NCT number
- NCT06460298
- Sponsor
- ProDa BioTech, LLC
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2026-07-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.